Full Text
The Full Text of this article is available as a PDF (283.9 KB).
References
- 1.Volhard F, Fahr T. Die. Brightsche Nierenkrankheit. Berlin: Springer; 1914. [Google Scholar]
- 2.Whitworth JA, Morel-Maroger L, Mignon F, et al. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron. 1976;16:1–19. doi: 10.1159/000180578. [DOI] [PubMed] [Google Scholar]
- 3.Lan HY, Nikolic-Paterson DJ, Mu W, et al. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-GBM glomerulonephritis. Clin Exp Immunol. 1997;110:233–40. doi: 10.1111/j.1365-2249.1997.tb08322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tomosugi NI, Cashman SJ, Hay H, et al. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumour necrosis factor, and IL-1. J Immunol. 1989;142:3083–90. [PubMed] [Google Scholar]
- 5.Rees AJ, Lockwood CM, Peters DK. Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J. 1977;2:723–36. doi: 10.1136/bmj.2.6089.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Morel-Maroger Striker L, Killen PD, Chi E, et al. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest. 1984;51:181–92. [PubMed] [Google Scholar]
- 7.Lan HY, Nikolic-Paterson DJ, Atkins RC. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest. 1992;67:743–51. [PubMed] [Google Scholar]
- 8.Tipping PG, Thomson NM, Holdsworth SR. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol. 1986;67:481–91. [PMC free article] [PubMed] [Google Scholar]
- 9.Mathieson PW, Thiru S, Peters DK, et al. Effects of Ancrod and rTPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis. Int J Exp Pathol. 1991;72:679–93. [PMC free article] [PubMed] [Google Scholar]
- 10.Border WA. Anticoagulants are of little value in the treatment of renal disease. Am J Kidney Dis. 1984;3:308–12. doi: 10.1016/s0272-6386(84)80051-7. [DOI] [PubMed] [Google Scholar]
- 11.Kincaid-Smith P. Anticoagulants are of value in the treatment of renal disease. Am J Kidney Dis. 1984;3:299–307. doi: 10.1016/s0272-6386(84)80050-5. [DOI] [PubMed] [Google Scholar]
- 12.Tipping PG, Lowe MG, Holdsworth SR. Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits. J Clin Invest. 1988;82:1253–9. doi: 10.1172/JCI113723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sady SP, Goyal M, Thomas PE, et al. Fibronectin mRNA in the developing glomerular crescent in rabbit antiglomerular basement membrane disease. J Am Soc Nephrol. 1995;5:2087–90. doi: 10.1681/ASN.V5122087. [DOI] [PubMed] [Google Scholar]
- 14.Chadban SJ, Tesch GH, Lan HY, et al. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Kidney Int. 1997;51:1809–17. doi: 10.1038/ki.1997.248. [DOI] [PubMed] [Google Scholar]
- 15.Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int. 1989;35:778–82. doi: 10.1038/ki.1989.52. [DOI] [PubMed] [Google Scholar]
- 16.Lloyd CM, Minto AW, Dorf ME, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med. 1997;185:1371–80. doi: 10.1084/jem.185.7.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med. 1997;185:1455–65. doi: 10.1084/jem.185.8.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Waddington S, Cook HT, Reaveley D, et al. L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int. 1996;49:1090–6. doi: 10.1038/ki.1996.158. [DOI] [PubMed] [Google Scholar]
- 19.Kitching AR, Holdsworth SR, Ploplis VA, et al. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med. 1997;185:963–8. doi: 10.1084/jem.185.5.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Shimuzu A, Masuda Y, Kitamura H, et al. Apoptosis in progressive crescentic glomerulonephritis. Lab Invest. 1996;74:941–51. [PubMed] [Google Scholar]
- 21.Ren K, Brentjens J, Chen Y, et al. Glomerular macrophage proliferation in experimental immune complex nephritis. Clin Immunol Immunopathol. 1991;60:384–98. doi: 10.1016/0090-1229(91)90095-r. [DOI] [PubMed] [Google Scholar]
- 22.Goto M, Matsuno K, Yamaguchi Y, et al. Proliferation kinetics of macrophage subpopulations in a rat experimental pancreatitis model. Arch Histol Cytol. 1993;56:75–82. doi: 10.1679/aohc.56.75. [DOI] [PubMed] [Google Scholar]
- 23.Burns AP, Fisher M, Li P, et al. Molecular analysis of HLA class II genes in Goodpasture's disease. Q J Med. 1995;88:93–100. [PubMed] [Google Scholar]
- 24.Kinjoh K, Kyogoku M, Good RA. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc Natl Acad Sci USA. 1993;90:3413–7. doi: 10.1073/pnas.90.8.3413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Huang X-R, Tipping PG, Shuo L, et al. Thl responsiveness to nephrogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 1997;51:94–103. doi: 10.1038/ki.1997.12. [DOI] [PubMed] [Google Scholar]